THE ASSOCIATION OF ENDOSCOPIC AND HISTOLOGIC ENDPOINTS WITH FAECAL CALPROTECTIN AND C-REACTIVE PROTEIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB
Remo Panaccione 1
Christophe Sapin 2
Faye Chan-Diehl 2
Richard Moses 2
Britta Siegmund 3
Alissa Walsh 4
Taku Kobayashi 5
Parambir Dulai 6
Simon Travis 7
1 University of Calgary, Calgary, Canada
2 Eli Lilly and Company, Indianapolis, United States
3 Charité - Universitätsmedizin Berlin, Berlin, Germany
4 St Vincent's Hospital, Sydney, Australia
5 Kitasato University Kitasato Institute Hospital, Minato-ku, Japan
6 University of California San Diego, La Jolla, United States
7 John Radcliffe Hospital, Oxford, United Kingdom
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]